Moderna's norovirus vaccine enters Phase III trials in the UK [Yahoo! Finance]
HilleVax, Inc. (HLVX)
Company Research
Source: Yahoo! Finance
This is the first vaccine trialled in the UK to target norovirus, a highly contagious virus that causes vomiting, diarrhoea, and stomach cramps. Often referred to as the “winter stomach bug”, it tends to spread during colder months. While norovirus affects people of all ages, vulnerable groups like the elderly can experience more severe illness. The Phase III NOVA 301 trial (NCT06592794) aims to recruit 2,500 participants across 39 sites in the UK. Participants will be randomly assigned receive either mRNA-1403 or a placebo. Although anyone aged 18 or older who meets the inclusion criteria can participate, researchers are specifically focused on enrolling those aged 60 and older. Norovirus puts the NHS under huge strain every winter, costing taxpayers around £100m ($129.75) annually, explained UK Health Secretary Wes Streeting. Sarah Collins, commercial director at the UK Health Security Agency added: “Norovirus isn't just a nasty tummy bug – it can have serious consequences for
Show less
Read more
Impact Snapshot
Event Time:
HLVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLVX alerts
High impacting HilleVax, Inc. news events
Weekly update
A roundup of the hottest topics
HLVX
News
- HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company ProgressGlobeNewswire
- What Makes HilleVax (HLVX) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- HilleVax, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by HilleVax (HLVX)Accesswire
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by HilleVax, Inc. (HLVX)Accesswire
- Investors who lost money on HilleVax, Inc. should contact Levi & Korsinsky about an ongoing investigation - HLVXAccesswire
HLVX
Earnings
- 8/8/24 - Miss
HLVX
Sec Filings
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- 10/16/24 - Form 8-K
- HLVX's page on the SEC website